Cancer patients surveyed online demonstrated low awareness of VTE risks, with only 24% and 15% having heard of DVT and PE, respectively, and 3% recognizing cancer treatments as risk factors.
Cross-Sectional (n=500)
Patients with cancer are at increased risk for venous thromboembolism (VTE). An online survey to measure PE/DVT terminology awareness and understanding of VTE risks revealed 24% and 15% of the 500 cancer patients surveyed had heard of term DVT/PE; 19% and 17% could name signs/ symptoms of DVT/PE; 3% recognized cancer treatments as risk factors for DVT/PE. Only 25% of the patients received prevention education from providers; <50% received VTE prophylaxis. Cancer patient awareness of VTE terminology and cancer and/or its treatment as risk for VTE is low. More effective patient/physician dialogue about VTE risk and thromboprophylaxis is needed.
Aggarwal et al. (Thu,) conducted a cross-sectional in Cancer (n=500). Cancer patients surveyed online demonstrated low awareness of VTE risks, with only 24% and 15% having heard of DVT and PE, respectively, and 3% recognizing cancer treatments as risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: